"Search" is our twice-yearly newsletter to supporters. In our latest edition of Spring Search issue, we look at the latest research news including how our scientists are developing improved breast ...

The ICR, in collaboration with The Royal Marsden NHS Foundation Trust, has now taken delivery of the latest genome sequencing device, the NovaSeq X Plus. In this blog post, Mark Jones speaks with ...

A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for some men than the current standard PSA blood test, a new study reports. Results ...

Breast cancer remains a leading cause of cancer-related deaths globally, with triple-negative breast cancer (TNBC) presenting particular therapeutic challenges due to its aggressive nature and limited ...

Professor Trevor Graham's group harnesses artificial intelligence and the principles of evolution with the aim of improving cancer prevention, diagnosis and treatment. Trevor Graham is Professor of ...

Scientists have unveiled a cutting-edge research platform powered by artificial intelligence (AI) that will revolutionise cancer research by allowing researchers to integrate and analyse large and ...

In the largest and most comprehensive study of its kind, researchers have provided further evidence that a hormone responsible for regulating breast development acts as a risk factor for breast cancer ...

Our group's aim is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma. The goal of our laboratory is to improve the treatment and survival of ...

Scientists from The Institute of Cancer Research, London, are part of a team of international researchers who have secured £5.5million in funding to find smarter, kinder treatments for people living ...